Social Anxiety and Avoidance in Head and Neck Cancer Patients
21 Years
70 Years
Both
Anxiety Disorder, Head and Neck Cancer, Lung Cancer
Trial Information
Social Anxiety and Avoidance in Head and Neck Cancer Patients
OBJECTIVES:
- Determine the relationship between treatment-provoked social anxiety and avoidance in
patients previously treated for head and neck cancer.
- Determine the relationship between pre-cancer psychiatric diagnosis and post-treatment
social anxiety and avoidance in these patients.
- Determine the effect of social anxiety and/or avoidance on the quality of life of these
patients.
- Investigate the specificity of these relationships in patients with head and neck
cancer by comparing patients with head and neck cancer to patients with lung cancer.
OUTLINE: This is a cross-sectional study. Patients are stratified according to prior
treatment type (significantly impairing [surgery] vs less impairing
[chemotherapy/radiotherapy]).
Patients undergo a face-to-face interview with a mental health clinician over 2 hours.
Patients complete multiple psychiatric/psychological assessments during the interview,
including the Structured Clinical Interview for DSM-IV (SCID); the Liebowitz Social Anxiety
Scale (SAS); the Performance Status Scale for Head and Neck Cancer Patients (PSS-HN); the
Social Phobia and Anxiety Inventory (SPAI); the State-Trait Anxiety Inventory (STAI);
Response to Stress Questionnaire, Cancer Version (RSQ-CV); the Functional Assessment of
Cancer Therapy (FACT-HNC (head neck cancer) or LC); the Voice Handicap Index (VHI); and the
Body Image Scale (BIS).
Cancer treatment and medical history information are gathered from patients' medical
records.
Inclusion Criteria
PATIENT CHARACTERISTICS:
- Diagnosis of 1 of the following:
- Head and neck cancer
- Lung cancer (control group)
- Must have received treatment for head and neck cancer or lung cancer within the past
5 years
PATIENT CHARACTERISTICS:
- Able to speak and read English to answer surveys, interviews, and questionnaires
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Prospective
Outcome Measure:
Level of social anxiety and avoidance in HNC patients post-treatment
Outcome Description:
Measured by the Liebowitz Social Anxiety Scale and the Social Phobia and Anxiety Inventory, containing 24 items with each item separately rated for fear as 0 (none), 1 (mild), 2 (moderate) to 3 (severe)and for avoidance behavior as 0 (never), 1 (occasionally), 2 (often), to 3 (usually). Scores are summed with lower values indicating lower levels of social anxiety and avoidance.
Outcome Time Frame:
at study entry, day 1
Safety Issue:
No
Principal Investigator
Kirsten Haman, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Vanderbilt-Ingram Cancer Center
Authority:
United States: Federal Government
Study ID:
VICC HN 0397
NCT ID:
NCT00483639
Start Date:
November 2003
Completion Date:
January 2008
Related Keywords:
- Anxiety Disorder
- Head and Neck Cancer
- Lung Cancer
- anxiety disorder
- long-term effects secondary to cancer therapy in adults
- head and neck cancer
- non-small cell lung cancer
- small cell lung cancer
- Anxiety Disorders
- Head and Neck Neoplasms
- Lung Neoplasms
Name | Location |
|---|---|
| Vanderbilt-Ingram Cancer Center | Nashville, Tennessee 37232-6838 |
| MBCCOP - Meharry Medical College - Nashville | Nashville, Tennessee 37208-3599 |
